Back to search

Switzerland· 66907002

Mektovi 15 mg, Filmtabletten

A binimetinib product containing binimetinibum, registered in Switzerland by Pierre Fabre Pharma SA and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01EE03

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedMektovi 15 mg, FilmtablettenATCL01EE03REGISTER NO.66907002PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Binimetinib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EE03 (binimetinib), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Binimetinib · ATC L01EE03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of binimetinib costs, country by country.

Normalised to the WHO defined daily dose (90 mg), so markets compare like for like.

  • Switzerland: $202.25 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Binimetinib · price per daily dose (90 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$202.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
binimetinibum
Manufacturer
Pierre Fabre Pharma SA
Country
Switzerland (CH)
ATC code
L01EE03
ATC class
Binimetinib
Defined daily dose
90 mg, O
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680669070021
    Blist 168 Stk
    CHF 4688.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

211 interactions on record for binimetinib.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Binimetinib · interactions on record

211 records

  • 31 severe
  • 180 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • TipranavirJ05AE09severe
  • DasatinibL01EA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Binimetinib in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All binimetinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Mektovi
  • Liechtenstein · Mektovi
  • Norway · Mektovi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2860e2e-c4ce-427f-83b4-dbf871cd7669
GET /v1/drugs/f2860e2e-c4ce-427f-83b4-dbf871cd7669?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "binimetinibum 15 mg",
  "valid_from": "2024-04-01",
  "limitations": "[{\"description\":\"Wird nur in Kombination mit BRAFTOVI zur Behandlung von erwachsenen Patienten mit nicht-resezierbarem oder metastasiertem Melanom mit einer BRAF-V600-Mutation vergütet.<br>\\nDie Therapie wird nur bis zur Progression der Krankheit vergütet.<br>\\nDie Behandlung bedarf der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.<br>\\n<br>\\nDie Pierre Fabre Pharma AG erstattet nach Aufforderung durch denjenigen Krankenversicherer, bei dem die versicherte Person zum Zeitpunkt des Bezugs versichert war, auf die Kombination von BRAFTOVI und MEKTOVI für jede bezogene MEKTOVI Packung (=Indikator für einen Behandlungszyklus) 24.49% des Fabrikabgabepreises zurück. Die Mehrwertsteuer kann nicht zusätzlich zu diesem Anteil des Fabrikabgabepreises zurückgefordert werden. Die Aufforderung zur Rückvergütung soll ab dem Zeitpunkt der Verabreichung erfolgen.<br>\\n<br>\\nFolgender Indikationscode ist an den Krankenversicherer zu übermitteln: 20875.01<br>\\n<br>\",\"costApproval\":null,\"indication\":\"20875.01\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-04-01\",\"validTo\":\"2027-03-31\"}]",
  "galenic_form": "Filmtabl 15 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2019-12-01",
  "self_retention_pct": 10
}

See everything about binimetinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.